Mounjaro Side Effects UK:
What to Expect and How to Manage Them

The most frequently reported side effects of Mounjaro (tirzepatide) are gastrointestinal—a direct consequence of how the medication slows gastric emptying and reduces gut motility. According to the Mounjaro SmPC, the following occur in more than 1 in 10 patients:

• Nausea — the most commonly reported symptom, particularly at treatment initiation and after dose increases
• Diarrhoea — loose stools, often in the first few weeks of treatment
• Constipation — caused by reduced gut motility; see our dedicated constipation guide
• Bloating and stomach discomfort — gas, fullness, and abdominal cramping
• Reduced appetite — the intended therapeutic effect, but can feel pronounced initially
• Vomiting — less common than nausea, but reported by some patients

Mounjaro is administered as a weekly subcutaneous injection, and localised reactions at the injection site are common—reported in approximately 1 in 7 patients.

• Redness (erythema) — mild flushing or redness around the injection site
• Mild swelling or induration — a small lump under the skin
• Itching or bruising — transient and usually resolves within a day or two

Most injection site reactions are mild and resolve within a few days. To minimise them:

• Rotate injection sites — use the abdomen, thigh, or upper arm, and change location each week
• Allow the pen to reach room temperature before injecting — cold medication from the fridge causes more discomfort
• Apply a cool compress for a few minutes after injection to reduce localised inflammation

Beyond gastrointestinal symptoms, other side effects reported in clinical trials and real-world use include:

• Fatigue — particularly in the first few weeks as the body adapts to reduced calorie intake
• Headaches — sometimes associated with reduced food or fluid intake; usually mild
• Mild dizziness — can be related to blood pressure changes or reduced intake
• Temporary hair thinning — not a formally listed adverse effect, but reported; linked to rapid weight loss (telogen effluvium) rather than the medication directly

If you experience unusual or persistent symptoms not covered here, report them via the MHRA Yellow Card Scheme. This system helps regulators monitor real-world drug safety.

The duration of side effects varies by symptom type:

Mounjaro is titrated gradually from 2.5mg to a maximum of 15mg over several months. Each dose increase typically brings a temporary return of gastrointestinal symptoms—particularly nausea, fatigue, and stomach discomfort.

• Temporary nausea — often resolves within 1–2 weeks of the new dose
• Mild fatigue — as the body adjusts to the stronger appetite suppression
• Stomach discomfort and bloating — more pronounced initially at each new dose level

These are expected and do not indicate a problem with the medication. Apply the same management strategies (small meals, hydration, rest) and allow 2–4 weeks for adaptation. If side effects at a new dose are severe or unmanageable, discuss a slower titration schedule with your clinician.

For nausea

• Eat smaller, more frequent meals — 4–5 small meals rather than 2–3 large ones
• Avoid greasy, spicy, or strong-smelling foods — these amplify nausea on a slowed stomach
• Eat cold or room-temperature foods — hot food has more odour and can worsen nausea
• Try ginger or peppermint tea — both have mild anti-nausea properties
• Do not lie down immediately after eating — stay upright for at least 30–60 minutes

For constipation

• Increase water intake to 6–8 glasses daily and add fibre gradually. See our full Mounjaro constipation guide for a complete management plan.
• Walk for 10–15 minutes after meals to stimulate gut motility.
• Consider osmotic laxatives (Movicol) or psyllium husk if dietary changes are insufficient.

For diarrhoea

• Stay hydrated — replace lost fluids with water and oral rehydration salts
• Eat simple, bland foods — rice, bananas, toast, boiled chicken
• Avoid dairy, high-fat, and high-fibre foods temporarily until symptoms settle
• Avoid caffeine and alcohol during episodes

For injection site reactions

• Rotate injection sites consistently — abdomen, thigh, upper arm
• Let the pen warm to room temperature before use
• Apply a cool compress after injection to reduce swelling and itching

Serious side effects are rare but require immediate medical attention. Seek urgent care if you experience:

• Severe abdominal pain — may indicate pancreatitis, a rare but serious complication
• Yellowing of the skin or whites of the eyes (jaundice) — may indicate liver or gallbladder issues
• Difficulty breathing, facial swelling, or rash — signs of a serious allergic reaction (anaphylaxis)
• Signs of low blood sugar (hypoglycaemia) — particularly if taking insulin or other diabetes medications alongside Mounjaro

Contact your GP, pharmacist, or prescribing clinician if:

• Side effects persist beyond 6 weeks without improvement
• Nausea, vomiting, or diarrhoea is severe enough to affect daily function or prevent adequate fluid intake
• You are unable to tolerate a dose increase — a slower titration schedule may be appropriate
• You notice unexpected symptoms not covered in the patient information leaflet
• Side effects are significantly affecting your quality of life

Do not stop Mounjaro without discussing it with your clinician first. Abrupt cessation causes appetite to return rapidly, and most side effects are manageable with clinical support rather than stopping treatment.